Relationship between carbon dioxide gradient/arteriovenous oxygen gradient index and lactate in septic shock secondary to pneumonia
DOI:
https://doi.org/10.24265/horizmed.2020.v20n2.04Keywords:
Carbon dioxide, Oxygen consumption, Septic shock, Cell hypoxiaAbstract
Objective: To determine the relationship between carbon dioxide gradient/arteriovenous oxygen gradient index and lactate in patients with pneumonia complicated by septic shock in areas delivering care for critically ill or injured patients of the Hospital III EsSalud Chimbote between 2018 and 2019. Materials and methods: A quantitative, observational, correlational, longitudinal trend study. The study population consisted of patients with pneumonia complicated by septic shock who had carbon dioxide gradient/arteriovenous oxygen gradient index and lactate readings. Results: Ninety (90) patients with pneumonia complicated by septic shock participated in the research. The present study showed a robust relationship between gas gradient index and serum lactate when monitoring patients at baseline, 3 hours, 6 hours and 12 hours. Conclusions: There is a relationship between carbon dioxide gradient/arteriovenous oxygen gradient index (> 1.4) and serum lactate levels in patients with septic shock secondary to pneumonia.
Downloads
References
Organización Panamericana de la Salud. Guía de Práctica Clínica: Neumonía adquirida en la comunidad en adultos. 2009. Disponible en: http://bvs.minsa.gob.pe/local/minsa/2418.pdf
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell G, Dean N, et al. Infectious Diseases Society of America/American Thoracic Society Consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis. 2007; 44(Suppl. 2): S27-72.
Finfer S, Machado FR. The global epidemiology of sepsis, does it matter that we know so little?. Am J Respir Crit Care Med. 2016; 193(3): 228-30.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock. Intensive Care Medicine. Springer Berlin Heidelberg; 2017. pp. 304-77.
Mayorga Espichán M. Estrategias para mejorar la sobrevivencia de los pacientes con sepsis severa. Acta Med Perú. 2010; 27(4): 302-9.
Dombrovskiy V, Martin A, Sunderram J, Paz H. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007; 35(5): 1244-50.
ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. New Engl J Med. 2014; 370(18): 1683-93.
Arroyo Sánches A, Camacho Cosavalente L. Trastornos ácido-base en la Unidad de Cuidados Intensivos del Hospital Víctor Lazarte Echegaray: incidencia, estancia hospitalaria y mortalidad. Acta Med Perú. 2007; 24(2): 91-5.
Martín GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. New Engl J Med. 2003; 348(16): 1546-54.
Angus DC, Pereira CA, Silva E. Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets. 2006; 6(2): 207-12.
Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. The epidemiology of septic shock in Intensive Care Units: the prospective multicenter cohort EPISS Study. Crit Care. 2013; 17(2): R65.
Hernández G, Luengo C, Bruhn A, Kattan E, Friedman G, OspinaTascon GA, et al. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014; 4(1): 1-9.
Ariza M, Gothard J, Macnaughton P, Hooper J, Morgan C, Evans T. Blood lactate and mixed venous-arterial PCO2 gradient as indices of poor peripheral perfusion following cardiopulmonary bypass surgery. Intensive Care Med. 1991; 17(6): 320-4.
Takami Y, Masumoto H. Mixed venous-arterial CO2 tension gradient after cardiopulmonary bypass. Asian Cardiovasc Thorac Ann. 2005; 13(3): 255-60.
Dubin A, Murias G, Estenssoro E, Canales H, Badie J, Pozo M, et al. Intramucosal-arterial pCO2 gap fails to reflect intestinal dysoxia in hypoxic hypoxia. Crit Care. 2002; 6(6): 514-20.
Lescano Alva C. Gases sanguíneos y trastornos ácido-base. Rev Peruana Med Intensiva. 2015; 5(3): 6-14.
Baigorri González F, Lorente Balanza JA. Oxigenación tisular y sepsis. Med Intensiva. 2005; 29(3): 178-84.
Ospina-Tascón G, Hernández G, Cecconi M. Understanding the venous-arterial CO2 to arterial-venous O2 content difference ratio. Intensive Care Med. 2016; 42(11): 4233-7.
He H, Long Y, Liu D, Wang X, Tang B. The prognostic value of central venous-to-arterial CO2 difference/arterial-central venous O2 difference ratio in septic shock patients with central venous O2 saturation > 80%. Shock. 2017; 48(5): 551-7.
Ochagavia A, Baigorri F, Mesquida J, Ayuela JM, Ferrándiz A, García X, et al. Monitorización hemodinámica en el paciente crítico. Recomendaciones del grupo de trabajo de Cuidados Intensivos cardiológicos y RCP de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias. Med Intensiva. 2014; 38(3): 154-69.
Vallée F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S, et al. Central venous to arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?. Intensive Care Med. 2008; 34(12): 2218-25.
Hernández Luna A, López Pérez H, Etulain González J, Olivera Guzmán C, Aguirre Sánchez J, Franco Granillo J. Delta de dióxido de carbono para valorar perfusión tisular como predictor de mortalidad en choque séptico. Med Crit. 2011; 25(2): 66-70.
Diaz del Castillo AH, Pérez Cely JA. Correlación entre el delta de CO2/Diferencia arteriovenosa con índice cardiaco en paciente en postoperatorio de cirugía cardiaca [Tesis]. Universidad de la Sabana: Colombia. Facultad de Medicina; 2011.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
